InfuSystem Q2 FY26 net income rises 24% to $3.2 million; revenue increases 2.6% to $36.9 million

PUBT · 1d ago
InfuSystem Q2 FY26 net income rises 24% to $3.2 million; revenue increases 2.6% to $36.9 million
  • InfuSystem posted GAAP net income of $3.2 million, or $0.15 per diluted share, up from $2.6 million, or $0.12 per diluted share.
  • Net revenues rose 2.6% to $36.9 million, with Patient Services up 15% to $24.8 million, offset by Device Solutions down 16% to $12.1 million.
  • Gross profit increased 8% to $21.4 million, lifting gross margin 2.8 percentage points to 58%.
  • Non-GAAP adjusted EBITDA climbed 8% to $8.6 million, with adjusted EBITDA margin up 1.1 percentage points to 23.4%.
  • CEO Carrie Lachance cited Oncology surpassing $20 million in quarterly revenue, reaffirming 2026 pro forma net revenue growth of 6% to 8%.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. InfuSystem Holdings Inc. published the original content used to generate this news brief via Business Wire (Ref. ID: 20260804145346) on August 04, 2026, and is solely responsible for the information contained therein.